🔗 Permalink

Inventor profile of:

Theis Terwey

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2025-07-31

Top Assignees for applications by Theis Terwey

The entities that hold a legal rights for patent applications filed by inventor Terwey Theis:

GH RESEARCH IRELAND LIMITED 24 Dublin 2, Ireland
GH Research Ireland Limited 3 Dublin, Ireland
GH RESEARCH IRELAND LIMITED 2 Dublin 4, Ireland

Recent patent applications by Terwey Theis

Theis Terwey from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-31

US20250241895A1

Human necessities

5-MEO-DMT FOR USE IN THE TREATMENT OF SLEEP DISTURBANCE

#2 | 2025-07-31

US20250241894A1

Human necessities

TREATMENT OF MENTAL DISORDERS

#3 | 2025-07-31

US20250241893A1

Human necessities

TREATMENT OF COGNITIVE DYSFUNCTION

#4 | 2025-07-31

US20250241892A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF PSYCHOMOTOR RETARDATION

#5 | 2025-07-31

US20250241891A1

Human necessities

TREATMENT OF ANXIETY

#6 | 2025-07-24

US20250235427A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF SOCIAL/EMOTIONAL WITHDRAWAL OR DETACHMENT

#7 | 2025-07-10

US20250221963A1

Human necessities

5-MEO-DMT FOR USE IN THE TREATMENT OF POSTPARTUM DEPRESSION

#8 | 2025-07-03

US20250213534A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF COGNITIVE DYSFUNCTION

#9 | 2025-07-03

US20250213533A1

Human necessities

5-MEO-DMT FOR USE IN THE TREATMENT OF SLEEP DISTURBANCE

#10 | 2025-07-03

US20250213532A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF BIPOLAR DISORDER

#11 | 2025-07-03

US20250213531A1

Human necessities

5-MEO-DTM FOR THE TREATMENT OF BIPOLAR DISORDER

#12 | 2025-07-03

US20250213530A1

Human necessities

5-MEO-DMT FOR USE IN THE TREATMENT OF NEGATIVE THINKING

#13 | 2025-07-03

US20250213529A1

Human necessities

5-METHOXY-N.N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF PSYCHOMOTOR RETARDATION

#14 | 2025-07-03

US20250213528A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF ANXIETY

#15 | 2025-06-26

US20250205256A1

Human necessities

5-MEO-DMT FOR USE IN THE TREATMENT OF NEGATIVE THINKING

#16 | 2025-06-26

US20250205200A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF POSTPARTUM DEPRESSION

#17 | 2025-06-26

US20250205199A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE FOR THE TREATMENT OF SOCIAL/EMOTIONAL WITHDRAWAL OR DETACHMENT

#18 | 2025-05-29

US20250170099A1

Human necessities

TREATMENT OF POSTNATAL DEPRESSION

#19 | 2025-05-01

US20250134861A1

Human necessities

COMPOSITIONS COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR USE IN TREATING MENTAL DISORDERS

#20 | 2024-09-19

US20240307350A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING DEPRESSION

#21 | 2024-04-11

US20240115550A1

Human necessities

TREATMENT OF MENTAL DISORDERS

#22 | 2024-04-11

US20240115549A1

Human necessities

TREATMENT OF MENTAL DISORDERS

#23 | 2024-04-04

US20240108602A1

Human necessities

TREATMENT OF MENTAL DISORDERS

#24 | 2024-04-04

US20240108601A1

Human necessities

TREATMENT OF MENTAL DISORDERS

#25 | 2023-03-09

US20230075124A1

Human necessities

AEROSOL COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE

#26 | 2022-10-13

US20220324802A1

Chemistry; metallurgy

METHOD FOR PURIFYING AN ORGANIC COMPOUND

#27 | 2022-03-10

US20220071958A1

Human necessities

5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR TREATING DEPRESSION

#28 | 2022-02-03

US20220031662A1

Human necessities

COMPOSITIONS COMPRISING 5-METHOXY-N,N-DIMETHYLTRYPTAMINE (5-MEO-DMT) FOR USE IN TREATING MENTAL DISORDERS

#29 | 2019-03-28

US20190091190A1

Human necessities

COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS

#30 | 2015-06-18

US20150164849A1

Human necessities

COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS

InventorID:

1193073 ⎘